Učitavanje...
Treatment of Infants Identified by Newborn Screening for Severe Combined Immunodeficiency
BACKGROUND: Severe combined immunodeficiency (SCID) is characterized by severely impaired T cell development and is fatal without treatment. Newborn screening (NBS) for SCID permits identification of affected infants before development of opportunistic infections and other complications. Substantial...
Spremljeno u:
| Izdano u: | J Allergy Clin Immunol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385855/ https://ncbi.nlm.nih.gov/pubmed/28270365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.01.005 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|